Risk Assessment and Management of Drug Inventory in Hospitals during COVID-19 Pandemic in Taiwan
Abstract Background The COVID-19 pandemic has caused the suspension of active pharmaceutical ingredients (APIs) production in China, the source of the global largest medication supply chain, resulting in the potential risks of hospital insufficient drug stocks affecting clinical treatment. If all drug inventory of the hospital increased, the short-term drug shortage risk can be reduced, but the inventory costs will be increased. Therefore, the purpose of this study is to establish a risk assessment mechanism for inventory management of APIs from China, to identify the medical priorities affected by drug shortages, and to plan different countermeasures to achieve the best effect of inventory management. Methods In this study, the tables of "Incidence of Drug Shortage" and "Impact Level of Drug Shortage" related to the risk of drug inventory were developed, which were evaluated in four levels respectively, and "Drug Shortage Risk Assessment Matrix" was designed according to the probability of drug shortage and impact according to the model data of Reproductive Number (R0) value and pandemic prediction. Each drug requiring APIs from China was evaluated and ranked according to the hazard index, so as to increase the different inventory and to find alternatives. Results We have evaluated the inventory risk level of drugs requiring APIs from China through the risk assessment mechanism, and increased the different backup stock according to the levels. The total increasing purchase amount was NTD 4.85 million, which could reduce the stock cost by about 2/3 compared with NTD 14.61 million of the total inventories for three months. Conclusions The study shows that there are significant differences between scientific inventory management and general method during COVID-19 pandemic. It can provide a reliable reference for other hospitals to adjust drug stocks in the face of other emerging infectious diseases or major emergencies by using the innovative mechanism.